Aliakbarian, M., Ashrafzadeh, K., Ferns, G. A., Hadian, R., Khodashahi, R., & Arjmand, M. (2025). NADPH Oxidase: A Potential Therapeutic Target to Reduce Primary Sclerosis Cholangitis Following Liver Transplantation. Current medicinal chemistry, 32(32), 8598. https://doi.org/10.2174/0109298673356252250213105931
Citace podle Chicago (17th ed.)Aliakbarian, Mohsen, Kiarash Ashrafzadeh, Gordon A. Ferns, Reyhaneh Hadian, Rozita Khodashahi, a Mohammad-Hassan Arjmand. "NADPH Oxidase: A Potential Therapeutic Target to Reduce Primary Sclerosis Cholangitis Following Liver Transplantation." Current Medicinal Chemistry 32, no. 32 (2025): 8598. https://doi.org/10.2174/0109298673356252250213105931.
Citace podle MLA (9th ed.)Aliakbarian, Mohsen, et al. "NADPH Oxidase: A Potential Therapeutic Target to Reduce Primary Sclerosis Cholangitis Following Liver Transplantation." Current Medicinal Chemistry, vol. 32, no. 32, 2025, p. 8598, https://doi.org/10.2174/0109298673356252250213105931.